Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05437588 · ClinicalTrials.gov registry record · NA
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
A NA study of Depression and Major Depressive Disorder, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 2
- Study locations
NCT05437588 is a NA study of Depression and Major Depressive Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 240 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05437588, a NA study of Depression and Major Depressive Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on improvement in depressive and suicidal behavior and on biomarkers (e.g. miRNA) for these disorders.
Conditions Studied
Interventions
- GENETIC Genetic testing
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
- UAB Huntsville Regional Medical Campus - Huntsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05437588
The ClinicalTrials.gov registry entry for NCT05437588 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Genetic testing is the first listed.
NCT05437588 reports 2 study locations spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05437588 about?
NCT05437588 is a clinical study titled "Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents". This study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on improvement in depressi...
What is the current status of trial NCT05437588?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2022-10-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05437588 study?
This clinical trial studies the following conditions: Depression, Major Depressive Disorder, Suicide, Suicide, Attempted, Depression in Adolescence.
What interventions are being tested in trial NCT05437588?
The interventions under investigation include: Genetic testing (GENETIC).
Who is sponsoring clinical trial NCT05437588?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05437588 being conducted?
This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.